| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 9.15e-08 | 16 | 55 | 4 | GO:0015385 | |
| GeneOntologyMolecularFunction | metal cation:proton antiporter activity | 8.62e-07 | 27 | 55 | 4 | GO:0051139 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.16e-06 | 29 | 55 | 4 | GO:0035325 | |
| GeneOntologyMolecularFunction | antiporter activity | 2.14e-06 | 138 | 55 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 2.25e-06 | 34 | 55 | 4 | GO:0015125 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC9B1 TMC7 PSG4 ATRAID PSG9 SLC10A4 SLC9B2 SLC9A7 ABCC5 PSG8 SLC4A4 PKD1L3 SLC30A4 SLC9A6 | 2.60e-06 | 1180 | 55 | 14 | GO:0022857 |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 5.87e-06 | 43 | 55 | 4 | GO:0140828 | |
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 7.04e-06 | 14 | 55 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | transporter activity | SLC9B1 TMC7 PSG4 ATRAID PSG9 SLC10A4 SLC9B2 SLC9A7 ABCC5 PSG8 SLC4A4 PKD1L3 SLC30A4 SLC9A6 | 7.24e-06 | 1289 | 55 | 14 | GO:0005215 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 7.40e-06 | 171 | 55 | 6 | GO:0015081 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 1.62e-05 | 296 | 55 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 3.37e-05 | 23 | 55 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 3.80e-05 | 465 | 55 | 8 | GO:0046873 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 4.13e-05 | 70 | 55 | 4 | GO:1901618 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 4.54e-05 | 477 | 55 | 8 | GO:0022804 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 4.87e-05 | 73 | 55 | 4 | GO:0170055 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 5.57e-05 | 149 | 55 | 5 | GO:1990782 | |
| GeneOntologyMolecularFunction | filamin binding | 6.87e-05 | 29 | 55 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.10e-04 | 90 | 55 | 4 | GO:0008028 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.50e-04 | 293 | 55 | 6 | GO:0008514 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 1.74e-04 | 301 | 55 | 6 | GO:0022853 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC9B1 SLC10A4 SLC9B2 SLC9A7 ABCC5 SLC4A4 PKD1L3 SLC30A4 SLC9A6 | 2.07e-04 | 758 | 55 | 9 | GO:0015318 |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 2.59e-04 | 45 | 55 | 3 | GO:0043495 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 2.78e-04 | 210 | 55 | 5 | GO:0019903 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC9B1 TMC7 SLC10A4 SLC9B2 SLC9A7 SLC4A4 PKD1L3 SLC30A4 SLC9A6 | 2.89e-04 | 793 | 55 | 9 | GO:0015075 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 2.99e-04 | 627 | 55 | 8 | GO:0022890 | |
| GeneOntologyMolecularFunction | glycolipid binding | 3.33e-04 | 49 | 55 | 3 | GO:0051861 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 4.39e-04 | 664 | 55 | 8 | GO:0008324 | |
| GeneOntologyMolecularFunction | alpha-catenin binding | 4.83e-04 | 12 | 55 | 2 | GO:0045294 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 6.64e-04 | 14 | 55 | 2 | GO:0015386 | |
| GeneOntologyMolecularFunction | phosphatase binding | 7.89e-04 | 264 | 55 | 5 | GO:0019902 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 1.24e-03 | 19 | 55 | 2 | GO:0022821 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 1.32e-03 | 173 | 55 | 4 | GO:0070851 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.66e-03 | 85 | 55 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | proton transmembrane transporter activity | 1.78e-03 | 188 | 55 | 4 | GO:0015078 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 1.82e-03 | 23 | 55 | 2 | GO:0016493 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 2.08e-03 | 196 | 55 | 4 | GO:0005319 | |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 2.32e-03 | 26 | 55 | 2 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 2.32e-03 | 26 | 55 | 2 | GO:0004950 | |
| GeneOntologyMolecularFunction | cadherin binding | 2.38e-03 | 339 | 55 | 5 | GO:0045296 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 2.53e-03 | 207 | 55 | 4 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 2.58e-03 | 208 | 55 | 4 | GO:0005342 | |
| GeneOntologyMolecularFunction | taste receptor activity | 3.72e-03 | 33 | 55 | 2 | GO:0008527 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 3.95e-03 | 34 | 55 | 2 | GO:0042910 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 4.18e-03 | 35 | 55 | 2 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 4.18e-03 | 35 | 55 | 2 | GO:0071814 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 8.71e-03 | 51 | 55 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 1.00e-02 | 1099 | 55 | 8 | GO:0008092 | |
| GeneOntologyMolecularFunction | actin binding | 1.01e-02 | 479 | 55 | 5 | GO:0003779 | |
| GeneOntologyBiologicalProcess | regulation of intracellular pH | 5.13e-06 | 94 | 55 | 5 | GO:0051453 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 6.40e-06 | 14 | 55 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of cellular pH | 7.30e-06 | 101 | 55 | 5 | GO:0030641 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 7.41e-06 | 47 | 55 | 4 | GO:0015721 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 7.98e-06 | 15 | 55 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 7.98e-06 | 15 | 55 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 7.98e-06 | 15 | 55 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 7.98e-06 | 15 | 55 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 9.80e-06 | 16 | 55 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.19e-05 | 17 | 55 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.19e-05 | 17 | 55 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.19e-05 | 17 | 55 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 1.42e-05 | 18 | 55 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 1.43e-05 | 116 | 55 | 5 | GO:0045670 | |
| GeneOntologyBiologicalProcess | regulation of pH | 1.69e-05 | 120 | 55 | 5 | GO:0006885 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.85e-05 | 59 | 55 | 4 | GO:0045671 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.98e-05 | 20 | 55 | 3 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 2.31e-05 | 21 | 55 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 2.31e-05 | 21 | 55 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 2.31e-05 | 21 | 55 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 2.67e-05 | 22 | 55 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte proliferation | 2.88e-05 | 134 | 55 | 5 | GO:0070664 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 3.02e-05 | 337 | 55 | 7 | GO:0006898 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 3.06e-05 | 23 | 55 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.06e-05 | 23 | 55 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | vascular process in circulatory system | 3.45e-05 | 344 | 55 | 7 | GO:0003018 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 3.49e-05 | 24 | 55 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 3.49e-05 | 24 | 55 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 3.49e-05 | 24 | 55 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 3.64e-05 | 70 | 55 | 4 | GO:0045124 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 3.96e-05 | 25 | 55 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 3.96e-05 | 25 | 55 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 5.01e-05 | 27 | 55 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte differentiation | 5.10e-05 | 151 | 55 | 5 | GO:1902106 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 5.61e-05 | 28 | 55 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 6.16e-05 | 80 | 55 | 4 | GO:0046850 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 6.24e-05 | 29 | 55 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of hemopoiesis | 6.51e-05 | 159 | 55 | 5 | GO:1903707 | |
| GeneOntologyBiologicalProcess | cellular response to indole-3-methanol | 6.95e-05 | 5 | 55 | 2 | GO:0071681 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 7.11e-05 | 83 | 55 | 4 | GO:0002707 | |
| GeneOntologyBiologicalProcess | osteoclast differentiation | 7.12e-05 | 162 | 55 | 5 | GO:0030316 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 7.65e-05 | 31 | 55 | 3 | GO:0010544 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 7.80e-05 | 85 | 55 | 4 | GO:0002762 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 8.42e-05 | 32 | 55 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 8.42e-05 | 32 | 55 | 3 | GO:0070341 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 8.42e-05 | 32 | 55 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 8.55e-05 | 87 | 55 | 4 | GO:0001974 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 8.91e-05 | 275 | 55 | 6 | GO:0006814 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 9.25e-05 | 33 | 55 | 3 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 9.25e-05 | 33 | 55 | 3 | GO:2000252 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 1.01e-04 | 34 | 55 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 1.01e-04 | 34 | 55 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | response to indole-3-methanol | 1.04e-04 | 6 | 55 | 2 | GO:0071680 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 1.11e-04 | 35 | 55 | 3 | GO:1901142 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 1.11e-04 | 178 | 55 | 5 | GO:0022612 | |
| GeneOntologyBiologicalProcess | regulation of myeloid leukocyte differentiation | 1.23e-04 | 182 | 55 | 5 | GO:0002761 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 1.25e-04 | 96 | 55 | 4 | GO:0002704 | |
| GeneOntologyBiologicalProcess | bone resorption | 1.41e-04 | 99 | 55 | 4 | GO:0045453 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 1.42e-04 | 38 | 55 | 3 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 1.53e-04 | 39 | 55 | 3 | GO:0045717 | |
| GeneOntologyBiologicalProcess | fatty acid biosynthetic process | 1.54e-04 | 191 | 55 | 5 | GO:0006633 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.65e-04 | 40 | 55 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.78e-04 | 41 | 55 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 1.90e-04 | 107 | 55 | 4 | GO:0042130 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 1.91e-04 | 42 | 55 | 3 | GO:0090330 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 2.30e-04 | 208 | 55 | 5 | GO:0035725 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 2.35e-04 | 45 | 55 | 3 | GO:0048521 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte proliferation | 2.48e-04 | 332 | 55 | 6 | GO:0070663 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 2.51e-04 | 46 | 55 | 3 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 2.51e-04 | 46 | 55 | 3 | GO:0072574 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 2.68e-04 | 47 | 55 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 2.68e-04 | 47 | 55 | 3 | GO:0034104 | |
| GeneOntologyBiologicalProcess | metal ion transport | SLC9B1 SLC10A4 SLC9B2 SLC9A7 ABCC5 SLC4A4 PKD1L3 SLC30A4 SLC9A6 HCRT | 2.74e-04 | 1000 | 55 | 10 | GO:0030001 |
| GeneOntologyBiologicalProcess | liver morphogenesis | 3.03e-04 | 49 | 55 | 3 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 3.03e-04 | 49 | 55 | 3 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 3.22e-04 | 50 | 55 | 3 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 3.35e-04 | 124 | 55 | 4 | GO:0050672 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 3.35e-04 | 124 | 55 | 4 | GO:0034109 | |
| GeneOntologyBiologicalProcess | negative regulation of epithelial cell proliferation | 3.37e-04 | 226 | 55 | 5 | GO:0050680 | |
| GeneOntologyBiologicalProcess | negative regulation of cell development | 3.44e-04 | 353 | 55 | 6 | GO:0010721 | |
| GeneOntologyBiologicalProcess | negative regulation of mononuclear cell proliferation | 3.56e-04 | 126 | 55 | 4 | GO:0032945 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 3.61e-04 | 52 | 55 | 3 | GO:0031342 | |
| GeneOntologyBiologicalProcess | bone remodeling | 3.67e-04 | 127 | 55 | 4 | GO:0046849 | |
| GeneOntologyBiologicalProcess | regulation of tissue remodeling | 3.78e-04 | 128 | 55 | 4 | GO:0034103 | |
| GeneOntologyBiologicalProcess | regulation of branching involved in salivary gland morphogenesis | 3.78e-04 | 11 | 55 | 2 | GO:0060693 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 3.82e-04 | 53 | 55 | 3 | GO:0034110 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | TBXAS1 SLC9B1 DMXL2 LIMA1 ADRA1B LPL SLC9B2 SLC9A7 CD320 SLC4A4 SLC9A6 | 3.90e-04 | 1249 | 55 | 11 | GO:0048878 |
| GeneOntologyBiologicalProcess | organic anion transport | 4.18e-04 | 515 | 55 | 7 | GO:0015711 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid cell differentiation | 4.49e-04 | 134 | 55 | 4 | GO:0045638 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 4.50e-04 | 56 | 55 | 3 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 4.74e-04 | 375 | 55 | 6 | GO:0007162 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | 4.96e-04 | 246 | 55 | 5 | GO:0045216 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 5.51e-04 | 60 | 55 | 3 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 5.51e-04 | 60 | 55 | 3 | GO:0045922 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion | 5.53e-04 | 252 | 55 | 5 | GO:0022408 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 5.79e-04 | 61 | 55 | 3 | GO:0060259 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid biosynthetic process | 6.37e-04 | 260 | 55 | 5 | GO:0072330 | |
| GeneOntologyBiologicalProcess | tissue remodeling | 6.59e-04 | 262 | 55 | 5 | GO:0048771 | |
| GeneOntologyBiologicalProcess | circulatory system process | 6.80e-04 | 733 | 55 | 8 | GO:0003013 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 7.29e-04 | 66 | 55 | 3 | GO:0010543 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 3.22e-06 | 90 | 53 | 5 | GO:0016328 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 8.42e-06 | 16 | 53 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 1.55e-05 | 320 | 53 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | cell surface | CEACAM19 PSG4 PSG9 LPL CLEC4G MXRA8 PSG8 ACKR2 SLC4A4 ADGRE2 PKD1L3 CDH1 | 1.68e-05 | 1111 | 53 | 12 | GO:0009986 |
| GeneOntologyCellularComponent | basal plasma membrane | 2.97e-05 | 354 | 53 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 4.51e-05 | 378 | 53 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | ciliary membrane | 1.12e-04 | 98 | 53 | 4 | GO:0060170 | |
| GeneOntologyCellularComponent | adherens junction | 1.98e-04 | 212 | 53 | 5 | GO:0005912 | |
| GeneOntologyCellularComponent | recycling endosome | 2.45e-04 | 222 | 53 | 5 | GO:0055037 | |
| GeneOntologyCellularComponent | endosome | MON2 SLC9B2 ARFGEF2 SLC9A7 ABCC5 ACKR2 CD320 SLC30A4 CDH1 SLC9A6 | 6.13e-04 | 1167 | 53 | 10 | GO:0005768 |
| GeneOntologyCellularComponent | cell-cell junction | 6.95e-04 | 591 | 53 | 7 | GO:0005911 | |
| GeneOntologyCellularComponent | cell projection membrane | 7.51e-04 | 431 | 53 | 6 | GO:0031253 | |
| GeneOntologyCellularComponent | side of membrane | 1.52e-03 | 875 | 53 | 8 | GO:0098552 | |
| GeneOntologyCellularComponent | presynapse | 1.65e-03 | 886 | 53 | 8 | GO:0098793 | |
| GeneOntologyCellularComponent | cilium | 1.79e-03 | 898 | 53 | 8 | GO:0005929 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 1.94e-03 | 519 | 53 | 6 | GO:0009897 | |
| GeneOntologyCellularComponent | caveola | 2.81e-03 | 111 | 53 | 3 | GO:0005901 | |
| GeneOntologyCellularComponent | recycling endosome membrane | 2.89e-03 | 112 | 53 | 3 | GO:0055038 | |
| GeneOntologyCellularComponent | catenin complex | 2.98e-03 | 32 | 53 | 2 | GO:0016342 | |
| GeneOntologyCellularComponent | anchoring junction | 3.01e-03 | 976 | 53 | 8 | GO:0070161 | |
| GeneOntologyCellularComponent | apical part of cell | 3.73e-03 | 592 | 53 | 6 | GO:0045177 | |
| GeneOntologyCellularComponent | endosome membrane | 4.05e-03 | 602 | 53 | 6 | GO:0010008 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | 5.20e-03 | 1307 | 53 | 9 | GO:0030659 | |
| GeneOntologyCellularComponent | sperm principal piece | 5.57e-03 | 44 | 53 | 2 | GO:0097228 | |
| GeneOntologyCellularComponent | vesicle membrane | 5.68e-03 | 1325 | 53 | 9 | GO:0012506 | |
| GeneOntologyCellularComponent | plasma membrane raft | 6.17e-03 | 147 | 53 | 3 | GO:0044853 | |
| GeneOntologyCellularComponent | synaptic vesicle | 7.01e-03 | 300 | 53 | 4 | GO:0008021 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 7.40e-03 | 157 | 53 | 3 | GO:1902554 | |
| GeneOntologyCellularComponent | apical junction complex | 7.53e-03 | 158 | 53 | 3 | GO:0043296 | |
| GeneOntologyCellularComponent | apical plasma membrane | 7.70e-03 | 487 | 53 | 5 | GO:0016324 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 1.92e-05 | 17 | 44 | 3 | MP:0031047 | |
| MousePheno | abnormal skeletal muscle morphology | 2.34e-05 | 508 | 44 | 9 | MP:0000759 | |
| MousePheno | increased skeletal muscle triglyceride level | 3.72e-05 | 21 | 44 | 3 | MP:0031415 | |
| MousePheno | decreased susceptibility to viral infection | 4.33e-05 | 125 | 44 | 5 | MP:0002410 | |
| MousePheno | decreased fatty acid oxidation | 5.62e-05 | 24 | 44 | 3 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 8.07e-05 | 27 | 44 | 3 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 9.02e-05 | 28 | 44 | 3 | MP:0020950 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 1.23e-04 | 31 | 44 | 3 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 1.23e-04 | 31 | 44 | 3 | MP:0008964 | |
| MousePheno | decreased susceptibility to Riboviria infection | 1.25e-04 | 82 | 44 | 4 | MP:0020914 | |
| MousePheno | decreased susceptibility to infection | 1.37e-04 | 255 | 44 | 6 | MP:0002409 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 1.77e-04 | 35 | 44 | 3 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 1.93e-04 | 36 | 44 | 3 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 2.46e-04 | 39 | 44 | 3 | MP:0030022 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 3.52e-04 | 44 | 44 | 3 | MP:0031023 | |
| MousePheno | abnormal pancreatic beta cell physiology | 3.59e-04 | 196 | 44 | 5 | MP:0003562 | |
| MousePheno | abnormal endocrine pancreas physiology | 4.12e-04 | 202 | 44 | 5 | MP:0010147 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 4.28e-04 | 47 | 44 | 3 | MP:0031617 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 4.85e-04 | 49 | 44 | 3 | MP:0020948 | |
| MousePheno | small seminal vesicle | 5.05e-04 | 118 | 44 | 4 | MP:0001157 | |
| MousePheno | decreased energy expenditure | 5.21e-04 | 119 | 44 | 4 | MP:0004890 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 5.38e-04 | 120 | 44 | 4 | MP:0009786 | |
| MousePheno | decreased cellular glucose uptake | 6.11e-04 | 53 | 44 | 3 | MP:0003926 | |
| MousePheno | increased circulating leptin level | 6.27e-04 | 125 | 44 | 4 | MP:0005669 | |
| MousePheno | abnormal fatty acid oxidation | 6.45e-04 | 54 | 44 | 3 | MP:0010953 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 8.78e-04 | 60 | 44 | 3 | MP:0009790 | |
| MousePheno | pallor | 8.83e-04 | 239 | 44 | 5 | MP:0003717 | |
| MousePheno | abnormal lipid oxidation | 9.22e-04 | 61 | 44 | 3 | MP:0010951 | |
| MousePheno | abnormal susceptibility to infection | 1.04e-03 | 672 | 44 | 8 | MP:0001793 | |
| MousePheno | increased insulin secretion | 1.06e-03 | 64 | 44 | 3 | MP:0003058 | |
| MousePheno | abnormal glycogen homeostasis | 1.06e-03 | 144 | 44 | 4 | MP:0005438 | |
| MousePheno | abnormal seminal vesicle size | 1.18e-03 | 148 | 44 | 4 | MP:0004907 | |
| MousePheno | abnormal muscle cell glucose uptake | 1.21e-03 | 67 | 44 | 3 | MP:0004130 | |
| MousePheno | abnormal carbon dioxide production | 1.21e-03 | 67 | 44 | 3 | MP:0008962 | |
| MousePheno | abnormal colon morphology | 1.30e-03 | 152 | 44 | 4 | MP:0000495 | |
| Domain | Na_H_Exchanger | 5.66e-08 | 14 | 53 | 4 | PF00999 | |
| Domain | Cation/H_exchanger | 5.66e-08 | 14 | 53 | 4 | IPR006153 | |
| Domain | Na/H_exchanger_6 | 2.37e-05 | 3 | 53 | 2 | IPR002090 | |
| Domain | DUF1981 | 4.72e-05 | 4 | 53 | 2 | PF09324 | |
| Domain | DCB_dom | 4.72e-05 | 4 | 53 | 2 | IPR032629 | |
| Domain | Sec7_N | 4.72e-05 | 4 | 53 | 2 | IPR032691 | |
| Domain | DCB | 4.72e-05 | 4 | 53 | 2 | PF16213 | |
| Domain | Sec7_N | 4.72e-05 | 4 | 53 | 2 | PF12783 | |
| Domain | Sec7_C | 4.72e-05 | 4 | 53 | 2 | IPR015403 | |
| Domain | ARM-like | 1.12e-04 | 270 | 53 | 6 | IPR011989 | |
| Domain | V-set | 1.72e-04 | 184 | 53 | 5 | PF07686 | |
| Domain | Ig_V-set | 2.47e-04 | 199 | 53 | 5 | IPR013106 | |
| Domain | NaH_exchanger | 2.81e-04 | 9 | 53 | 2 | IPR004709 | |
| Domain | ARM-type_fold | 3.83e-04 | 339 | 53 | 6 | IPR016024 | |
| Domain | - | 4.09e-04 | 222 | 53 | 5 | 1.25.10.10 | |
| Domain | Cation/H_exchanger_CPA1 | 4.27e-04 | 11 | 53 | 2 | IPR018422 | |
| Domain | Ig_2 | 1.17e-03 | 73 | 53 | 3 | PF13895 | |
| Domain | LH2 | 1.17e-03 | 18 | 53 | 2 | SM00308 | |
| Domain | PLAT | 1.60e-03 | 21 | 53 | 2 | PF01477 | |
| Domain | PLAT | 1.60e-03 | 21 | 53 | 2 | PS50095 | |
| Domain | PLAT/LH2_dom | 1.60e-03 | 21 | 53 | 2 | IPR001024 | |
| Domain | - | 1.60e-03 | 21 | 53 | 2 | 2.60.60.20 | |
| Domain | - | 2.64e-03 | 97 | 53 | 3 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 2.79e-03 | 99 | 53 | 3 | IPR016186 | |
| Domain | CTDL_fold | 3.48e-03 | 107 | 53 | 3 | IPR016187 | |
| Domain | GPS | 4.18e-03 | 34 | 53 | 2 | SM00303 | |
| Domain | GPS | 4.43e-03 | 35 | 53 | 2 | PF01825 | |
| Domain | GPS | 4.68e-03 | 36 | 53 | 2 | PS50221 | |
| Domain | GPS | 4.94e-03 | 37 | 53 | 2 | IPR000203 | |
| Domain | HEAT | 8.20e-03 | 48 | 53 | 2 | PF02985 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 1.41e-04 | 99 | 38 | 4 | MM14624 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 2.52e-04 | 9 | 38 | 2 | M27337 | |
| Pathway | REACTOME_SODIUM_PROTON_EXCHANGERS | 2.52e-04 | 9 | 38 | 2 | MM15079 | |
| Pubmed | 2.98e-09 | 36 | 55 | 5 | 37497580 | ||
| Pubmed | Progesterone and HMOX-1 promote fetal growth by CD8+ T cell modulation. | 2.66e-08 | 20 | 55 | 4 | 25774501 | |
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 1.06e-06 | 13 | 55 | 3 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 1.06e-06 | 13 | 55 | 3 | 1985902 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 10964771 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 32169849 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 1.06e-06 | 13 | 55 | 3 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 1.06e-06 | 13 | 55 | 3 | 16638824 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 20044046 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 32150576 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 22469976 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 1.06e-06 | 13 | 55 | 3 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 1.06e-06 | 13 | 55 | 3 | 28035001 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 1.06e-06 | 13 | 55 | 3 | 12832451 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 1.06e-06 | 13 | 55 | 3 | 15316023 | |
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 1.06e-06 | 13 | 55 | 3 | 21670291 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 22162753 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 1.06e-06 | 13 | 55 | 3 | 23935487 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 2702644 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 8380065 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 1279194 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 15331748 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 1.06e-06 | 13 | 55 | 3 | 22406619 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 7628460 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 25724769 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 26374765 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 1.06e-06 | 13 | 55 | 3 | 25972571 | |
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 1.06e-06 | 13 | 55 | 3 | 22092845 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 11801635 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 28913658 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 19008452 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 1.06e-06 | 13 | 55 | 3 | 15220458 | |
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 1.06e-06 | 13 | 55 | 3 | 8500759 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 18843289 | ||
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 1.06e-06 | 13 | 55 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 1.06e-06 | 13 | 55 | 3 | 23800882 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 15207636 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 19285068 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 21760897 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 1.06e-06 | 13 | 55 | 3 | 1326665 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 21081647 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 11133662 | ||
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 1.06e-06 | 13 | 55 | 3 | 39168268 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 11483763 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 8402684 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 2164599 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 16619040 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 1.06e-06 | 13 | 55 | 3 | 8209741 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 1.06e-06 | 13 | 55 | 3 | 21949477 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 29396368 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 26219866 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 18003729 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 26284027 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 2133556 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 32521208 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 1.06e-06 | 13 | 55 | 3 | 33352461 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 19406938 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 38381498 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 20739537 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 1.06e-06 | 13 | 55 | 3 | 29967450 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 1633107 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 1.06e-06 | 13 | 55 | 3 | 19358828 | |
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 1.06e-06 | 13 | 55 | 3 | 27695943 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 20404914 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 16680193 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 26911181 | ||
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 1653760 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 1.06e-06 | 13 | 55 | 3 | 32027621 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 1.06e-06 | 13 | 55 | 3 | 27777319 | |
| Pubmed | 1.06e-06 | 13 | 55 | 3 | 18848945 | ||
| Pubmed | 1.35e-06 | 14 | 55 | 3 | 37531413 | ||
| Pubmed | 1.35e-06 | 14 | 55 | 3 | 23780386 | ||
| Pubmed | 1.35e-06 | 14 | 55 | 3 | 28567513 | ||
| Pubmed | 1.35e-06 | 14 | 55 | 3 | 8207827 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 1.35e-06 | 14 | 55 | 3 | 34666041 | |
| Pubmed | 1.35e-06 | 14 | 55 | 3 | 19700760 | ||
| Pubmed | 1.35e-06 | 14 | 55 | 3 | 34619794 | ||
| Pubmed | Expression patterns of CD66a and CD117 in the mouse submandibular gland. | 1.35e-06 | 14 | 55 | 3 | 25498293 | |
| Pubmed | Endothelial barrier function is differentially regulated by CEACAM1-mediated signaling. | 1.35e-06 | 14 | 55 | 3 | 29746166 | |
| Pubmed | 1.35e-06 | 14 | 55 | 3 | 9212243 | ||
| Pubmed | CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo. | 1.35e-06 | 14 | 55 | 3 | 27572314 | |
| Pubmed | 1.35e-06 | 14 | 55 | 3 | 1648219 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 1.35e-06 | 14 | 55 | 3 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 1.35e-06 | 14 | 55 | 3 | 32209360 | |
| Pubmed | 1.35e-06 | 14 | 55 | 3 | 11994468 | ||
| Pubmed | 1.35e-06 | 14 | 55 | 3 | 11850617 | ||
| Pubmed | CEACAM2 positively regulates integrin αIIbβ3-mediated platelet functions. | 1.35e-06 | 14 | 55 | 3 | 27161904 | |
| Pubmed | 1.35e-06 | 14 | 55 | 3 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 1.35e-06 | 14 | 55 | 3 | 26196244 | |
| Pubmed | 1.35e-06 | 14 | 55 | 3 | 8896983 | ||
| Interaction | RAB4A interactions | 2.68e-06 | 457 | 53 | 9 | int:RAB4A | |
| Interaction | SIGLECL1 interactions | 1.17e-05 | 113 | 53 | 5 | int:SIGLECL1 | |
| Cytoband | 4q24 | 8.00e-04 | 34 | 56 | 2 | 4q24 | |
| Cytoband | 19q13.2 | 1.08e-03 | 164 | 56 | 3 | 19q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q22 | 1.48e-03 | 183 | 56 | 3 | chr16q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q24 | 2.39e-03 | 59 | 56 | 2 | chr4q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 2.68e-03 | 473 | 56 | 4 | chr17q21 | |
| Cytoband | 17q21 | 2.72e-03 | 63 | 56 | 2 | 17q21 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 1.76e-06 | 11 | 41 | 3 | 1315 | |
| GeneFamily | Solute carriers | 2.67e-05 | 395 | 41 | 7 | 752 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 3.23e-05 | 163 | 41 | 5 | 590 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.19e-02 | 394 | 41 | 4 | 471 | |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | PDXDC1 GPR155 LYVE1 DMXL2 TLR1 C6orf120 PIGW SLC4A4 CDH1 SRPRB NKX1-2 | 2.19e-06 | 899 | 55 | 11 | M2242 |
| Coexpression | BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A | PDXDC1 GPR155 LYVE1 DMXL2 TLR1 C6orf120 PIGW SLC4A4 CDH1 SRPRB NKX1-2 | 3.03e-06 | 930 | 55 | 11 | MM893 |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 9.52e-06 | 135 | 55 | 5 | MM965 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 4.15e-05 | 32 | 55 | 3 | MM2 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 4.41e-05 | 93 | 55 | 4 | M40279 | |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | 5.01e-05 | 463 | 55 | 7 | MM1011 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 5.46e-05 | 35 | 55 | 3 | MM757 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP | 6.28e-05 | 200 | 55 | 5 | M6629 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 6.28e-05 | 200 | 55 | 5 | M5915 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 6.43e-05 | 201 | 55 | 5 | MM1294 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | 1.07e-04 | 224 | 55 | 5 | M40145 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 1.21e-04 | 230 | 55 | 5 | MM986 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 1.41e-04 | 48 | 55 | 3 | MM531 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 1.53e-04 | 128 | 55 | 4 | MM1000 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.22e-07 | 185 | 56 | 6 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-07 | 186 | 56 | 6 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-07 | 186 | 56 | 6 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.61e-07 | 194 | 56 | 6 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-06 | 182 | 56 | 5 | be48ce85991bceeff938ba080e6bf9cc62176b05 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.59e-06 | 185 | 56 | 5 | afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-06 | 187 | 56 | 5 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-06 | 187 | 56 | 5 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.98e-06 | 189 | 56 | 5 | 16e019fd6e2376110b767739754389891f391669 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.09e-06 | 190 | 56 | 5 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 4.41e-06 | 193 | 56 | 5 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | Control-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 4.41e-06 | 193 | 56 | 5 | 3479c01aaae7afd7e02d00e0cb21951c0106a0fd | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.52e-06 | 194 | 56 | 5 | df56e23f1dcf1902d29392fcc947e0e268e1648b | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.64e-06 | 195 | 56 | 5 | 4008fa86b5166087a4b20f89ae07e1dfc87c855d | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 4.64e-06 | 195 | 56 | 5 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | Control-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 4.64e-06 | 195 | 56 | 5 | b4444b67a709e82b8e2ee510924c3152cb88b051 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.87e-06 | 197 | 56 | 5 | 8b9a88fb671d5c2b25d291c851e2b8a478f2610c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.00e-06 | 198 | 56 | 5 | dbae6a58cb3ce8612755fbdba6194b70b35f258a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.12e-06 | 199 | 56 | 5 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.12e-06 | 199 | 56 | 5 | 98c0d57c247d39bc771d81f4387f8dd01222628e | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.12e-06 | 199 | 56 | 5 | 372fb9eb90022dc4ac770a75b4e207c33d1d0c43 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.12e-06 | 199 | 56 | 5 | 5ceeed92f831d068ff4bb3994f420002338330e7 | |
| ToppCell | cellseq2-Immune-Immune_Myeloid-IM|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.12e-06 | 199 | 56 | 5 | dd3bf59cdc18091889cbf6c43f37100ba537843d | |
| ToppCell | cellseq2-Immune-Immune_Myeloid|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.12e-06 | 199 | 56 | 5 | 6c3c9eceea20121ae17ae2462134aa0437f591b3 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.12e-06 | 199 | 56 | 5 | b818d46a39c8782188d82dc8931b8eec9d549dd1 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.12e-06 | 199 | 56 | 5 | ac866ae110967c5867ff4601939b79861d43df54 | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.25e-06 | 200 | 56 | 5 | 881ab995c90d75fd987d6e8f1f926a4bfcc4235f | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.25e-06 | 200 | 56 | 5 | 019340e8b4b4944a49e14fdec7ce2954cbb8ba2e | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.25e-06 | 200 | 56 | 5 | 78d75d381cb2b9a4c9eb7c32a07b014eaee39195 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-H-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.25e-06 | 200 | 56 | 5 | b6f21f5cc137eddf6ba90e81cae791b57d88d9d7 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.13e-06 | 98 | 56 | 4 | a74fb790c135bd0d0033df3aca7b789d8b25e361 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.13e-06 | 98 | 56 | 4 | cb0941481aef9068d7dbce0d1b6cf125f482a98d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.44e-05 | 156 | 56 | 4 | 60f1ce38e34b582f589db1e0d6139282c1902b2b | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.65e-05 | 166 | 56 | 4 | 941d6aa94ab9d36e5f6c40f446c926754e070d56 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.65e-05 | 166 | 56 | 4 | 6f5ecf3b2cf613ae0535ab3d21d93622f1497571 | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 5.79e-05 | 167 | 56 | 4 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-05 | 168 | 56 | 4 | 4ae9e9d93bcd6f4d5815e57fd5afa7a3398a0ec1 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-05 | 168 | 56 | 4 | 04e168fe1d6f5f9e3d3bf9d7c13e800e3594868a | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.06e-05 | 169 | 56 | 4 | 41ad349806b279fbe1374b7e3cc7f146a11adb44 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 169 | 56 | 4 | 454b92b9b67299a64278c010db033ca5b9d217a0 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 169 | 56 | 4 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.06e-05 | 169 | 56 | 4 | 2c851b2703c7b8b656026f996f5fc027e4a79b36 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 169 | 56 | 4 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 169 | 56 | 4 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.06e-05 | 169 | 56 | 4 | 42782c61592742190ab0cba8a94f8bdf9c278f90 | |
| ToppCell | droplet-Spleen-nan-24m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.34e-05 | 171 | 56 | 4 | 35acc5c3e36bc605603c0d45375f2cf3c3e9d4cd | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.49e-05 | 172 | 56 | 4 | e39ea2f4edbf36ebf9604fa6f9349081859c596c | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.49e-05 | 172 | 56 | 4 | 875ea290840e835952623b905eb610f3c71456d2 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Megakaryocyte/Platelet-Megakaryocyte/Platelet-Megakaryocyte/Platelet_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.49e-05 | 172 | 56 | 4 | bcc50bed47465daa953ba91f17d1ee4c947ab461 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.94e-05 | 175 | 56 | 4 | e991ffa4d1d278a011592b9915cd35fe76db20cc | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell-plasma_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.94e-05 | 175 | 56 | 4 | 28b29f844fa46fe579ddc19039fb2d9dc5f48f3b | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.94e-05 | 175 | 56 | 4 | ac96ca9ca309b0d72a2f5af6a3b02c7f80755750 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.09e-05 | 176 | 56 | 4 | b0b87eebcf5c994386b39ca607e17f10e9d9de74 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.25e-05 | 177 | 56 | 4 | 345cebc19f93970a9a46be139208b300081f5493 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.25e-05 | 177 | 56 | 4 | 67cc3a6461db5e0678f96b18224aeb83ad34b0f4 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 178 | 56 | 4 | 6c1b5087581ca8cea976d89ea6f34088c8fc3668 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 7.57e-05 | 179 | 56 | 4 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-05 | 179 | 56 | 4 | 1757b9f3f4c634277a67c4f5a39d27d6b4937073 | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 7.74e-05 | 180 | 56 | 4 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.74e-05 | 180 | 56 | 4 | 64f01494a4052186773720e10b4e7c724ff94547 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.74e-05 | 180 | 56 | 4 | 66c7b02d85e32ba3e7530d0c4aff17e7525ccdd8 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 7.74e-05 | 180 | 56 | 4 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.90e-05 | 181 | 56 | 4 | 8fcdab61fad2efd324d2b27c58f5a594f1dc15de | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.07e-05 | 182 | 56 | 4 | d5d6bc16458bc665e7ad6669040d79f73f640044 | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.07e-05 | 182 | 56 | 4 | 0b59ead4bb4486c7ec2ee90b94ee3a09905612c5 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.25e-05 | 183 | 56 | 4 | ec3c05b9ce1e0fbb720e0dea41f1e28fd3fd878f | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega-Erythrocytic_early|bone_marrow / Manually curated celltypes from each tissue | 8.25e-05 | 183 | 56 | 4 | d43ba3fbbd9132125fa2b7ea0891a2c577974f14 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.42e-05 | 184 | 56 | 4 | 157a3d00165bb4a8c52c3e63ae57d9cf57500be7 | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-05 | 184 | 56 | 4 | 15ea746c77785120f69f9ab370fb7eb9b70692f8 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-05 | 184 | 56 | 4 | 8fa30789c9d583188667cf375d2218e392dd40bc | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-alveolar_macrophage|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.42e-05 | 184 | 56 | 4 | bd5e8fc453a6393b8778734a2c3c2f1281769bcd | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 184 | 56 | 4 | 3261d767d5e3d9e9fbac22ad73ca14e44beed89c | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.60e-05 | 185 | 56 | 4 | 775b72319ef6acffd2c9a74293b9c1bccea33f42 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.60e-05 | 185 | 56 | 4 | 4bee178ede12f56ba5f5bec44a03dc2a62c50137 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.78e-05 | 186 | 56 | 4 | e152bdd837366e3e0b8bcfdb4d53f0685f2e803a | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-05 | 187 | 56 | 4 | 52ffd4be374e329ac8d321063f061b826d252956 | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_Erythro-Mega-Erythrocytic_early|lymph-node_spleen / Manually curated celltypes from each tissue | 8.96e-05 | 187 | 56 | 4 | 61d346c9873c2edb3ce224a0c063c54d9a68309e | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.15e-05 | 188 | 56 | 4 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | Monocytes-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 9.15e-05 | 188 | 56 | 4 | 756375cf9c9cccc4fb4a7f5e4756fa3fc36a7892 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.34e-05 | 189 | 56 | 4 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-05 | 189 | 56 | 4 | 287e59104687fe1665232c52993889f0f2c97f17 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.34e-05 | 189 | 56 | 4 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.34e-05 | 189 | 56 | 4 | 6d24414ac6bd4f03f7a5ad3a6eba51d549a7b112 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.34e-05 | 189 | 56 | 4 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | COPD-Myeloid-ncMonocyte|World / Disease state, Lineage and Cell class | 9.53e-05 | 190 | 56 | 4 | aece860b5609ad5a8fc920d685f0d0ec71bf9018 | |
| ToppCell | COPD-Myeloid-ncMonocyte|Myeloid / Disease state, Lineage and Cell class | 9.53e-05 | 190 | 56 | 4 | ed978cd5d9da87b49878a330e362762c487f849f | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.53e-05 | 190 | 56 | 4 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial-capillary_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.73e-05 | 191 | 56 | 4 | 38fe60a8570f3c6eb8e8f8646f90d505dfd7d647 | |
| ToppCell | facs-Lung-3m-Endothelial-capillary_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.73e-05 | 191 | 56 | 4 | 0e6cd2628a5cebd35e960e4eb3b52ddc9358031c | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.73e-05 | 191 | 56 | 4 | 718330bb97fe8a1ffd0c82e9af23311a32eacfe1 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.73e-05 | 191 | 56 | 4 | 454034ad940377ee079afa8ce33f8e0bdeaf44f8 | |
| ToppCell | Endothelial-B|World / shred on cell class and cell subclass (v4) | 9.73e-05 | 191 | 56 | 4 | 8b7857dee69d0ba3e59e230c9fd372e14695299e | |
| ToppCell | facs-Lung-Endomucin_-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-05 | 192 | 56 | 4 | ba3fe97786564dba1c8185f2802ce1b57f4f3cc9 | |
| ToppCell | facs-Lung-Endomucin_|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-05 | 192 | 56 | 4 | 85d4d0df701451daf95e94a87a0096da1e86533b | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-05 | 192 | 56 | 4 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | facs-Lung-18m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.92e-05 | 192 | 56 | 4 | dfa6adc776621f4b51d731b796c0421855b2297c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-05 | 192 | 56 | 4 | 2510f22197502f60fd266b7f42eff040f25b8ae7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-05 | 192 | 56 | 4 | e8e316f396834bcd34843e56e1d86f310fd6aada | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 193 | 56 | 4 | 2218833749576ba1a0fc95bd155c781e7e1163c6 | |
| ToppCell | Club_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.01e-04 | 193 | 56 | 4 | 6582c0367052b9d10fb629c383ee0c55872afd2d | |
| Drug | AC1L1IPV | 3.51e-06 | 43 | 55 | 4 | CID000004683 | |
| Disease | response to fluoropyrimidines | 3.05e-06 | 2 | 52 | 2 | EFO_0010825 | |
| Disease | cD177 antigen measurement | 4.13e-06 | 18 | 52 | 3 | EFO_0021866 | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 1.82e-05 | 4 | 52 | 2 | EFO_0801909 | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 4.55e-05 | 6 | 52 | 2 | EFO_0801907 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 6.06e-05 | 43 | 52 | 3 | EFO_0022290 | |
| Disease | triglycerides to total lipids in very large VLDL percentage | 1.14e-04 | 53 | 52 | 3 | EFO_0022340 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 1.14e-04 | 53 | 52 | 3 | EFO_0022258 | |
| Disease | cholesterol to total lipids in very large VLDL percentage | 1.20e-04 | 54 | 52 | 3 | EFO_0022244 | |
| Disease | squamous cell carcinoma, esophageal carcinoma | 1.36e-04 | 10 | 52 | 2 | EFO_0000707, EFO_0002916 | |
| Disease | free cholesterol in very large HDL measurement | 1.81e-04 | 62 | 52 | 3 | EFO_0022273 | |
| Disease | Nerve Degeneration | 4.29e-04 | 83 | 52 | 3 | C0027746 | |
| Disease | hyperglycemia (biomarker_via_orthology) | 6.26e-04 | 21 | 52 | 2 | DOID:4195 (biomarker_via_orthology) | |
| Disease | docosahexaenoic acid to total fatty acids percentage | 6.26e-04 | 21 | 52 | 2 | EFO_0022262 | |
| Disease | cholesterol to total lipids in medium LDL percentage | 1.04e-03 | 27 | 52 | 2 | EFO_0022238 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RTRAKSLLLATIVWA | 156 | O00590 | |
| EESVLWTILISILKL | 171 | Q7Z4R8 | |
| VLFLVTLWILKNRLS | 701 | Q9UHX3 | |
| REAWTSLLLLLLTKT | 1706 | Q9Y6D5 | |
| LVTRRKAILALLSVW | 156 | P35368 | |
| KAILALLSVWVLSTV | 161 | P35368 | |
| VKSRWVLLRSIDLVS | 1226 | Q8TDJ6 | |
| TLWSLIIAKLILSRS | 1086 | O94822 | |
| VKVSLWSLLVTLVVL | 266 | Q96EP9 | |
| SLVLLLTSIWTTRLL | 6 | Q9Y5Y7 | |
| WTSLSLRVTAKELSL | 11 | Q9UHB6 | |
| HTRSWAVLKLLLLLL | 241 | Q96AG4 | |
| ISIVSLISLIWSLAI | 386 | Q7Z3F1 | |
| LISLIWSLAILLLSK | 391 | Q7Z3F1 | |
| SLVTATLLLLSWLRA | 241 | Q9NPF0 | |
| RSLKWSLLLLSLLSF | 16 | O75752 | |
| LLVLTLAVWLQSLTA | 6 | P06858 | |
| RKLTTRILSDTTLWL | 111 | Q6P996 | |
| RKLTTRILSDTTLWL | 111 | Q6P474 | |
| TKTLLLTSLFLWIRT | 261 | P03886 | |
| ESTWKLAVSSLLRVL | 1456 | Q7Z3U7 | |
| KLLWTTSRVLKVLSV | 326 | P14923 | |
| TVLLTLLLWATSFTL | 161 | O95800 | |
| LVLGLLLTEIVRSWS | 221 | O15440 | |
| SLLLKTLVAGTIWNL | 246 | Q7Z4Q2 | |
| RVKTSTAAILTSLWL | 1776 | Q9H799 | |
| IWLARKIRSDLTALT | 21 | P26441 | |
| LVTLTRRAIKWSRLL | 36 | Q5TC63 | |
| FSKSLLLSASILVLW | 11 | Q7Z692 | |
| SISLDTLIAILKWSS | 396 | Q9P203 | |
| QRITWKGVLLTASLL | 11 | Q00888 | |
| RSLSALLLLLQVSSW | 6 | P12830 | |
| TKVSWAAVTLLLLLL | 6 | O43612 | |
| RILTALAISRISLVW | 46 | Q9NYV8 | |
| AVLLTLVFWKLIRSR | 46 | Q9Y5M8 | |
| LSVTLLLIFSIFWTK | 171 | Q96D59 | |
| LTLTILTIWLFKHRR | 81 | Q92581 | |
| LSWLKSRLKVLTEVS | 1181 | Q8NF91 | |
| LALSLSLTETQVKIW | 196 | Q9UD57 | |
| QRITWKGLLLTASLL | 11 | Q9UQ74 | |
| QRITWKGLLLTASLL | 11 | Q00887 | |
| WDITKLVKLLSSLVS | 1031 | Q7Z443 | |
| KWSSSLRSIALSIIL | 171 | Q86UD5 | |
| WIVASSLILLSSLLL | 376 | Q7Z7B1 | |
| WTSDILSLSKLRILI | 61 | Q15399 | |
| TLSVSILLWATQRRK | 211 | Q6UW56 | |
| TTVLWAVILSILLSK | 41 | Q6UXB4 | |
| VTVALSVALLALLKW | 16 | P24557 | |
| STVLLLLLFSWKTVK | 446 | Q8IUR5 | |
| ESLLITVLWRRLSTF | 76 | A0A1B0GVG6 | |
| LSSTEILKWLREILI | 591 | P21359 | |
| RTLSLAWEVASLLTL | 46 | Q8IWL8 | |
| TWSSILRSIALTIIL | 151 | Q4ZJI4 | |
| LSAIILTLLALWLSS | 151 | O14863 | |
| LALLWILKSTVAAII | 961 | Q9Y6R1 | |
| LTLTILTIWLFKHRR | 81 | Q96T83 | |
| WRTLEITSRLLILVL | 246 | Q6PP77 | |
| STIASLALSLLWIVK | 271 | Q7Z402 | |
| RILLWKLVLLQSSAV | 6 | Q9BRK3 |